Symbol="RPRX"
AssetType="Common Stock"
Name="Royalty PharmaÂ Plc"
Description="Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York."
CIK="1802768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="110 EAST 59TH STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="13642891000"
EBITDA="1056029000"
PERatio="55.25"
PEGRatio="-0.02"
BookValue="13.95"
DividendPerShare="0.78"
DividendYield="0.0263"
EPS="0.55"
RevenuePerShareTTM="5.31"
ProfitMargin="0.108"
OperatingMarginTTM="0.446"
ReturnOnAssetsTTM="0.0378"
ReturnOnEquityTTM="0.0466"
RevenueTTM="2361384000"
GrossProfitTTM="1332971000"
DilutedEPSTTM="0.55"
QuarterlyEarningsGrowthYOY="-0.277"
QuarterlyRevenueGrowthYOY="0.004"
AnalystTargetPrice="48.26"
TrailingPE="55.25"
ForwardPE="10.85"
PriceToSalesRatioTTM="8.14"
PriceToBookRatio="2.994"
EVToRevenue="10.37"
EVToEBITDA="21.32"
Beta="0.387"
num_52WeekHigh="43.67"
num_52WeekLow="28.98"
num_50DayMovingAverage="30.54"
num_200DayMovingAverage="35.62"
SharesOutstanding="448927000"
DividendDate="2023-09-15"
ExDividendDate="2023-08-17"
symbol="RPRX"
open="30.45"
high="30.86"
low="30.10"
price="30.73"
volume="1924314.00"
latest_trading_day="2023-08-29"
previous_close="30.39"
change="0.34"
change_percent="1.1188%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="2151316"
Change_recent_avg="-0.06"
Delta_recent_avg="0.62"
Variance_recent_avg="0.31"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="159"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0017.jpeg"
image_negative_thumbnail_id_2="1161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="578"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_positive_thumbnail_id_1="608"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_positive_thumbnail_id_2="619"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
